Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis

  • K. Sugihara
  • , Y. Kobayashi
  • , A. Suzuki
  • , N. Tamura
  • , K. Motamedchaboki
  • , C. T. Huang
  • , T. O. Akama
  • , J. Pecotte
  • , P. Frost
  • , C. Bauer
  • , J. B. Jimenez
  • , J. Nakayama
  • , D. Aoki
  • , M. N. Fukuda

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans.

Original languageEnglish
Article number4478
JournalNature communications
Volume5
DOIs
Publication statusPublished - 22-07-2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis'. Together they form a unique fingerprint.

Cite this